INHIBRX
Summary
Inhibrx is a clinical-stage biopharmaceutical company focused on developing biologic therapeutics in oncology and orphan diseases.
Deals Overview
Total Dealss1
Valued Deals1
Total Value£ 1.34 B
Avg. Deal Size£ 1.34 B
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
All rights reserved. Copyright © 2025 Datasite
